Advertisement

Cell Biochemistry and Biophysics

, Volume 71, Issue 3, pp 1445–1456 | Cite as

Revealing the Strong Functional Association of adipor2 and cdh13 with adipoq: A Gene Network Study

  • Susmita Bag
  • Anand Anbarasu
Original Paper

Abstract

In the present study, we have analyzed functional gene interactions of adiponectin gene (adipoq). The key role of adipoq is in regulating energy homeostasis and it functions as a novel signaling molecule for adipose tissue. Modules of highly inter-connected genes in disease-specific adipoq network are derived by integrating gene function and protein interaction data. Among twenty genes in adipoq web, adipoq is effectively conjoined with two genes: Adiponectin receptor 2 (adipor2) and cadherin 13 (cdh13). The functional analysis is done via ontological briefing and candidate disease identification. We observed that the highly efficient-interlinked genes connected with adipoq are adipor2 and cdh13. Interestingly, the ontological aspect of adipor2 and cdh13 in the adipoq network reveal the fact that adipoq and adipor2 are involved mostly in glucose and lipid metabolic processes. The gene cdh13 indulge in cell adhesion process with adipoq and adipor2. Our computational gene web analysis also predicts potential candidate disease recognition, thus indicating the involvement of adipoq, adipor2, and cdh13 with not only with obesity but also with breast cancer, leukemia, renal cancer, lung cancer, and cervical cancer. The current study provides researchers a comprehensible layout of adipoq network, its functional strategies and candidate disease approach associated with adipoq network.

Keywords

Gene networks Adipoq Adipor2 Cdh13 Obesity 

Abbreviations

ADIPOQ

Adiponectin

ADIPOR2

Adiponectin receptor 2

CDH13

Cadherin 13

STRING

Search tool for retrieval of interacting genes/protein

PINA

Protein interaction network analysis

DIP

Database of interacting proteins

BIND

Biomolecular interaction network database

HPRD

Human protein reference database

Notes

Acknowledgments

A.A. gratefully acknowledges the Indian council of Medical Research (ICMR), Government of India Agency for the research Grant [IRIS ID: 2014-0099]. S.B. thanks ICMR for the Senior Research Fellowship. The authors would also like to thank the management of VIT University for providing the necessary facilities to carry out this research project.

References

  1. 1.
    Segal, E., et al. (2005). From signatures to models: Understanding cancer using microarrays. Nature Genetics, 37, 38–45.CrossRefGoogle Scholar
  2. 2.
    Bernardo, D. D., et al. (2005). Chemogenomic profiling on a genome-wide scale using reverse-engineered gene networks. National Biotechnology, 23(3), 377–383.CrossRefGoogle Scholar
  3. 3.
    Gardner, T. S., et al. (2003). Inferring genetic networks and identifying compound mode of action via expression profiling. Science, 301(5629), 102–105.CrossRefPubMedGoogle Scholar
  4. 4.
    Calvano, S. E., et al. (2005). A network-based analysis of systemic inflammation in humans. Nature, 437(7061), 1032–1037.CrossRefPubMedGoogle Scholar
  5. 5.
    Jiang, W., Li, X., et al. (2008). Constructing disease-specific gene networks using pair-wise relevance metric: Application to colon cancer identifies interleukin 8, desmin and enolase 1 as the central elements. BMC Systems Biology, 2, 72.CrossRefPubMedCentralPubMedGoogle Scholar
  6. 6.
    Anitha, P., et al. (2014). Computational gene network study on antibiotic resistance genes of Acinetobacter baumannii. Computers in Biology and Medicine, 48, 17–27.CrossRefPubMedGoogle Scholar
  7. 7.
    Hayasaka, S., Hugenschmidt, C. E., & Laurienti, P. J. (2011). A network of genes, genetic disorders, and brain areas. PLoS ONE, 6(6), e20907.CrossRefPubMedCentralPubMedGoogle Scholar
  8. 8.
    Jacob, F., & Monod, J. (1961). Genetic regulatory mechanisms in the synthesis of proteins. Journal of Molecular Biology, 3, 318–356.CrossRefPubMedGoogle Scholar
  9. 9.
    Franke, L., et al. (2006). Reconstruction of a functional human gene network, with an application for prioritizing positional candidate genes. American Journal of Human Genetics, 78, 1011–1025.CrossRefPubMedCentralPubMedGoogle Scholar
  10. 10.
    Xenarios, I., Rice, D. W., et al. (2000). DIP: The database of interacting proteins. Nucleic Acids Research, 28(1), 289–291.CrossRefPubMedCentralPubMedGoogle Scholar
  11. 11.
    Alfarano, C., Andrade, C. E., et al. (2005). The biomolecular interaction network database and related tools 2005 update. Nucleic Acids Research, 33, 418–424.CrossRefGoogle Scholar
  12. 12.
    Chatr Aryamontri, A., Breitkreutz, B. J., et al. (2013). The BioGRID interaction database: 2013 update. Nucleic Acids Research, 41, 816–823.CrossRefGoogle Scholar
  13. 13.
    Keshava, P. T. S., Goel, R., et al. (2009). Human protein reference database—2009 update. Nucleic Acids Research, 37(1), 767–772.CrossRefGoogle Scholar
  14. 14.
    Kerrien, S., Aranda, B., et al. (2012). The IntAct molecular interaction database in 2012. Nucleic Acids Research, 40(D1), 841–846.CrossRefGoogle Scholar
  15. 15.
    WHO. (2000). The problem of overweight and obesity. Obesity: Preventing and managing the global epidemic. Report of a WHO Consultation. WHO Technical Report Series, Series 894 (pp. 5–37).Google Scholar
  16. 16.
    Zimmet, P. Z., & Alberti, K. G. (2006). Introduction: Globalization and the non-communicable disease epidemic. Obesity (Silver Spring), 14(1), 1–3.CrossRefGoogle Scholar
  17. 17.
    Qi, L., & Cho, Y. A. (2008). Gene–environment interaction and obesity. Nutrition Reviews, 66(12), 684–694.CrossRefPubMedCentralPubMedGoogle Scholar
  18. 18.
    Ogden, C. L., Yanovski, S. Z., et al. (2010). The epidemiology of obesity. Gastroenterology, 39(1), 1–7.Google Scholar
  19. 19.
    Hu, E., Liang, P., et al. (1996). AdipoQ is a novel adipose-specific gene dysregulated in obesity. Journal of Biological Chemistry, 271(18), 10697–10703.CrossRefPubMedGoogle Scholar
  20. 20.
    Belahsen, R., Bermudez, O. I., et al. (2005). Obesity and related metabolic disorders are prevalent in Moroccan women of child-bearing age. International Journal of Diabetes and Metabolism, 13, 159–166.Google Scholar
  21. 21.
    Enns, J. E., Taylor, C. G., et al. (2011). Variations in adipokine genes AdipoQ, Lep, and LepR are associated with risk for obesity-related metabolic disease: The modulatory role of gene–nutrient interactions. Journal of Obesity, 2011(2011), 1–17.CrossRefGoogle Scholar
  22. 22.
    Grundy, S. M. (2004). Obesity, metabolic syndrome, and cardiovascular disease. Journal of Clinical Endocrinology and Metabolism, 89, 2595–2600.CrossRefPubMedGoogle Scholar
  23. 23.
    Sharma, A. M. (2002). Adipose tissue: A mediator of cardiovascular risk. International Journal of Obesity and Related Metabolic Disorder, 26(4), 5–7.CrossRefGoogle Scholar
  24. 24.
    Klaus, S. (2004). Adipose tissue as a regulator of energy balance. Current Drug Targets, 5, 241–250.CrossRefPubMedGoogle Scholar
  25. 25.
    Trayhurn, P., & Wood, I. S. (2004). Adipokines: Inflammation and the pleiotropic role of white adipose tissue. British Journal Nutrition, 92, 347–355.CrossRefGoogle Scholar
  26. 26.
    Kyriakou, T., Collins, L. J., Spencer-Jones, N. J., Malcolm, C., Wang, X., Snieder, H., et al. (2008). Adiponectin gene ADIPOQ SNP associations with serum adiponectin in two female populations and effects of SNPs on promoter activity. Journal of Human Genetics, 53(8), 718–727.CrossRefPubMedCentralPubMedGoogle Scholar
  27. 27.
    Valle, M., et al. (2005). Low-grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome. Diabetes and Metabolism, 31(1), 55–62.CrossRefPubMedGoogle Scholar
  28. 28.
    Comuzzie, A. G., et al. (2001). The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. Journal of Clinical Endocrinology and Metabolism, 86, 4321–4325.CrossRefPubMedGoogle Scholar
  29. 29.
    Kissebah, A. H., Sonnenberg, G. E., Myklebust, J., et al. (2000). Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proceedings of the National Academy of Sciences, 97, 14478–14483.CrossRefGoogle Scholar
  30. 30.
    Snel, B., Lehmann, G., et al. (2000). STRING: A web-server to retrieve and display the repeatedly occurring neighbourhood of a gene. Nucleic Acids Research, 28, 3442–3444.CrossRefPubMedCentralPubMedGoogle Scholar
  31. 31.
    Von Mering, C., Huynen, M., et al. (2003). STRING: A database of predicted functional associations between proteins. Nucleic Acids Research, 31, 258–261.CrossRefGoogle Scholar
  32. 32.
    Von Mering, C., Jensen, L. J., et al. (2005). STRING: Known and predicted protein–protein associations integrated and transferred across organisms. Nucleic Acids Research, 33, 433–437.CrossRefGoogle Scholar
  33. 33.
    Von Mering, C., Jensen, L. J., et al. (2007). STRING 7—Recent developments in the integration and prediction of protein interactions. Nucleic Acids Research, 35, 358–362.CrossRefGoogle Scholar
  34. 34.
    Jensen, L. J., Kuhn, M., et al. (2009). STRING 8—A global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Research, 37, 412–416.CrossRefGoogle Scholar
  35. 35.
    Szklarczyk, D., et al. (2011). The STRING database in 2011: Functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Research, 39, 561–568.CrossRefGoogle Scholar
  36. 36.
    Warde-Farley, D., et al. (2010). The GeneMANIA prediction server: Biological network integration for gene prioritization and predicting gene function. Nucleic Acids Research, 38, 214–220.CrossRefGoogle Scholar
  37. 37.
    Kanehisa, M., et al. (2004). The KEGG resource for deciphering the genome. Nucleic Acids Research, 32, 277–280.CrossRefGoogle Scholar
  38. 38.
    Croft, D., et al. (2010). Reactome: A database of reactions, pathways and biological processes. Nucleic Acids Research, 39, 691–697.CrossRefGoogle Scholar
  39. 39.
    Datta, S., et al. (2009). Computational biology touches all bases. Genome Biology, 10(2), 303.CrossRefPubMedCentralPubMedGoogle Scholar
  40. 40.
    Cowley, M. J., et al. (2012). PINA v2.0: Mining interactome modules. Nucleic Acids Research, 40, 862–865.CrossRefGoogle Scholar
  41. 41.
    Martin, A., et al. (2010). BisoGenet: A new tool for gene network building, visualization and analysis. BMC Bioinformatics, 10, 91.CrossRefGoogle Scholar
  42. 42.
    Lee, I., et al. (2011). Prioritizing candidate disease genes by network-based boosting of genome-wide association data. Genome Research, 21(7), 1109–1121.CrossRefPubMedCentralPubMedGoogle Scholar
  43. 43.
    Shannon, P., et al. (2003). Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Research, 13(11), 2498–2504.CrossRefPubMedCentralPubMedGoogle Scholar
  44. 44.
    Peng, Y., et al. (2006). SNPs3D: Candidate gene and SNP selection for association studies. BMC Bioinformatics, 7, 166.CrossRefGoogle Scholar
  45. 45.
    Li, J., et al. (2009). Building disease-specific drug-protein connectivity maps from molecular interaction networks and PubMed abstracts. PLoS Computational Biology, 5, 1–15.CrossRefGoogle Scholar
  46. 46.
    Yamauchi, T., et al. (2003). Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature, 423(6941), 762–769.CrossRefPubMedGoogle Scholar
  47. 47.
    Neumeier, M., et al. (2005). Regulation of adiponectin receptor 1 in human hepatocytes by agonists of nuclear receptors. Biochemical and Biophysical Research Communications, 334(3), 924–929.CrossRefPubMedGoogle Scholar
  48. 48.
    Kuroyanagi, K., et al. (2008). Citrus auraptene acts as an agonist for PPARs and enhances adiponectin production and MCP-1 reduction in 3T3-L1 adipocytes. Biochemical and Biophysical Research Communications, 366(1), 219–225.CrossRefPubMedGoogle Scholar
  49. 49.
    Hug, C., et al. (2004). T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proceeding of National Academy of Sciences U S A, 101(28), 10308–10313.CrossRefGoogle Scholar
  50. 50.
    Monda, K. L., et al. (2010). The genetics of obesity and the metabolic syndrome. Endocrine, Metabolic and Immune Disorders Drug Targets, 10(2), 86–108.CrossRefPubMedGoogle Scholar
  51. 51.
    Awazawa, M., et al. (2009). Adiponectin suppresses hepatic SREBP1c expression in an AdipoR1/LKB1/AMPK dependent pathway. Biochemical and Biophysical Research Communications, 382(1), 51–56.CrossRefPubMedGoogle Scholar
  52. 52.
    Park, B. H., et al. (2004). Phosphorylation of C/EBPbeta at a consensus extracellular signal-regulated kinase/glycogen synthase kinase 3 site is required for the induction of adiponectin gene expression during the differentiation of mouse fibroblasts into adipocytes. Molecular Cell Biology, 24(19), 8671–8680.CrossRefGoogle Scholar
  53. 53.
    Kern, P. A., et al. (2004). Perilipin expression in human adipose tissue is elevated with obesity. Journal of Clinical Endocrinology and Metabolism, 89(3), 1352–1358.CrossRefPubMedGoogle Scholar
  54. 54.
    Mao, X., et al. (2006). APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function. Nature Cell Biology, 8(5), 516–523.CrossRefPubMedGoogle Scholar
  55. 55.
    Morínigo, R., et al. (2006). Intra-abdominal fat adiponectin receptors expression and cardiovascular metabolic risk factors in obesity and diabetes. Obesity Surgery, 16(6), 745–751.CrossRefPubMedGoogle Scholar
  56. 56.
    Miyoshi, H., et al. (2010). Perilipin overexpression in mice protects against diet-induced obesity. Journal of Lipid Research, 51(5), 975–982.CrossRefPubMedCentralPubMedGoogle Scholar
  57. 57.
    Garvey, W. T., et al. (1992). Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM. Diabetes, 41(4), 465–475.CrossRefPubMedGoogle Scholar
  58. 58.
    Loo, L. H., Lin, H. J., Singh, D. K., et al. (2009). Heterogeneity in the physiological states and pharmacological responses of differentiating 3T3-L1 preadipocytes. Journal of Cell Biology, 187(3), 375–384.CrossRefPubMedCentralPubMedGoogle Scholar
  59. 59.
    Ceddia, R. B., Somwar, R., Maida, A., et al. (2005). Globular adiponectin increases GLUT4 translocation and glucose uptake but reduces glycogen synthesis in rat skeletal muscle cells. Diabetologia, 48(1), 132–139.CrossRefPubMedGoogle Scholar
  60. 60.
    Terra, X., et al. (2011). FABP 4 is associated with inflammatory markers and metabolic syndrome in morbidly obese women. European Journal of Endocrinology, 164(4), 539–547.CrossRefPubMedGoogle Scholar
  61. 61.
    Dobrian, A. D. (2006). The complex role of PPARgamma in renal dysfunction in obesity: Managing a Janus-faced receptor. Vascular Pharmacology, 45(1), 36–45.CrossRefPubMedGoogle Scholar
  62. 62.
    Gregoire, F. M., et al. (1998). Understanding adipocyte differentiation. Physiological Reviews, 78(3), 783–809.PubMedGoogle Scholar
  63. 63.
    Sato, M., Mori, Y., et al. (1998). The H-cadherin (CDH13) gene is inactivated in human lung cancer. Human Genetics, 103(1), 96–101.CrossRefPubMedGoogle Scholar
  64. 64.
    Kola, B., et al. (2008). The role of AMP-activated protein kinase in obesity. Frontiers of Hormone Research, 36, 198–211.PubMedGoogle Scholar
  65. 65.
    Pruitt, K., et al. (2006). Inhibition of SIRT1 reactivates silenced cancer genes without loss of promoter DNA hypermethylation. PLoS Genetics, 2(3), 0344–0352.CrossRefGoogle Scholar
  66. 66.
    Kadowaki, T., et al. (2006). Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. Journal of Clinical Investigation, 116(7), 1784–1792.CrossRefPubMedCentralPubMedGoogle Scholar
  67. 67.
    Körner, A., et al. (2007). Total and high-molecular-weight adiponectin in breast cancer: In vitro and in vivo studies. Journal of Clinical Endocrinology and Metabolism, 92(3), 1041–1048.CrossRefPubMedGoogle Scholar
  68. 68.
    Spyridopoulos, T. N., et al. (2007). Low adiponectin levels are associated with renal cell carcinoma: A case-control study. International Journal of Cancer, 120(7), 1573–1578.CrossRefGoogle Scholar
  69. 69.
    Broedl, U. C., et al. (2009). Low adiponectin levels are an independent predictor of mixed and non-calcified coronary atherosclerotic plaques. PLoS ONE, 4(3), e4733.CrossRefPubMedCentralPubMedGoogle Scholar
  70. 70.
    Mistry, T., et al. (2006). The regulation of adiponectin receptors in human prostate cancer cell lines. Biochemical and Biophysical Research Communications, 348(3), 832–838.CrossRefPubMedGoogle Scholar
  71. 71.
    Kotronen, A., et al. (2009). Genetic variation in the ADIPOR2 gene is associated with liver fat content and its surrogate markers in three independent cohorts. European Journal of Endocrinology, 160(4), 593–602.CrossRefPubMedGoogle Scholar
  72. 72.
    Kremmidiotis, G., et al. (1998). Localization of human cadherin genes to chromosome regions exhibiting cancer-related loss of heterozygosity. Genomics, 49(3), 467–471.CrossRefPubMedGoogle Scholar
  73. 73.
    Widschwendter, A., et al. (2004). CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patients. International Journal of Cancer, 109(2), 163–166.CrossRefGoogle Scholar
  74. 74.
    Kim, D. S., et al. (2007). Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features. Cancer, 110(12), 2785–2792.CrossRefPubMedGoogle Scholar
  75. 75.
    Brock, M. V., et al. (2008). DNA methylation markers and early recurrence in stage I lung cancer. The New England Journal of Medicine, 358(11), 1118–1128.CrossRefPubMedGoogle Scholar
  76. 76.
    Shinichi, T., et al. (2002). Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas. Cancer Research, 62(12), 3382–3386.Google Scholar
  77. 77.
    Hibi, K., et al. (2004). CDH13 promoter region is specifically methylated in poorly differentiated colorectal cancer. British Journal of Cancer, 90(5), 1030–1033.CrossRefPubMedCentralPubMedGoogle Scholar
  78. 78.
    Matuschek, C., et al. (2010). Methylated APC and GSTP1 genes in serum DNA correlate with the presence of circulating blood tumor cells and are associated with a more aggressive and advanced breast cancer disease. European Journal of Medical Research, 15, 277–286.PubMedCentralPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Medical and Biological Computing Laboratory, School of Biosciences and TechnologyVIT UniversityVelloreIndia

Personalised recommendations